Cargando…

2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt

BACKGROUND: CLABSI caused by CRKP is associated with high mortality. Identification of the genetic basis for carbapenem resistance is crucial for selecting the proper antimicrobial therapy, and testing for bacterial clonality. We aimed to study the genetic basis of CRKP causing CLABSI in 3 ICUs, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kholy, Amany El, Manakhly, Arwa El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254051/
http://dx.doi.org/10.1093/ofid/ofy210.1953
_version_ 1783373634615640064
author Kholy, Amany El
Manakhly, Arwa El
author_facet Kholy, Amany El
Manakhly, Arwa El
author_sort Kholy, Amany El
collection PubMed
description BACKGROUND: CLABSI caused by CRKP is associated with high mortality. Identification of the genetic basis for carbapenem resistance is crucial for selecting the proper antimicrobial therapy, and testing for bacterial clonality. We aimed to study the genetic basis of CRKP causing CLABSI in 3 ICUs, and use ERIC PCR to test for their clonality. METHODS: The study was conducted in a tertiary care hospital in Egypt from January 1, 2016 to December 31, 2017 after approval by the Institution Review Board. We enrolled all patients with CVCs in 3 ICUs. At least 2 sets of blood cultures were collected from each febrile patient by BACT/ALERT system (Bio Merieux, France), before starting an antibiotic. The pathogens and their antimicrobial susceptibility were detected by the VITEK 2 system (Bio Merieux, France). Phenotypic detection of carbapenemase activity was done by modified Hodge (MHT) test and Carba-NP test. Multiplex PCR was done to identify the carbapenemase genes. Molecular typing of carbapenem-resistant isolates was performed by ERIC–PCR. RESULTS: We enrolled 1,210 patients admitted for 17,785 ICU days. Central catheters were utilized in 53.3% of patients for a total of 11,014 central line days. Out of 130 Gram-negative CLABSI pathogens detected, we identified carbapenem resistance in 57 (43.8%); of which K. pneumoniae was the predominant pathogen (27 out of 57, 47.4%). By MHT and carba-NP, 63.79% of K. pneumoniae isolates were carbapenemase producers. Multiplex PCR revealed bla(NDM) in 48.14% and bla(KPC) in 33.33% of the K. pneumoniae isolates, whereas bla(OXA-48) was not detected. ERIC-PCR analysis of 27 CRKP isolates showed genetic relatedness among only 5 KPC-positive and 2 producers, while most isolates were polyclonal. CONCLUSION: We detected a high rate of carbapenem resistance among K. pneumoniae causing CLABSI showing bla(NDM) in 48.14% and bla(KPC) in 33.33%; and they were mostly polyclonal. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254051
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62540512018-11-28 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt Kholy, Amany El Manakhly, Arwa El Open Forum Infect Dis Abstracts BACKGROUND: CLABSI caused by CRKP is associated with high mortality. Identification of the genetic basis for carbapenem resistance is crucial for selecting the proper antimicrobial therapy, and testing for bacterial clonality. We aimed to study the genetic basis of CRKP causing CLABSI in 3 ICUs, and use ERIC PCR to test for their clonality. METHODS: The study was conducted in a tertiary care hospital in Egypt from January 1, 2016 to December 31, 2017 after approval by the Institution Review Board. We enrolled all patients with CVCs in 3 ICUs. At least 2 sets of blood cultures were collected from each febrile patient by BACT/ALERT system (Bio Merieux, France), before starting an antibiotic. The pathogens and their antimicrobial susceptibility were detected by the VITEK 2 system (Bio Merieux, France). Phenotypic detection of carbapenemase activity was done by modified Hodge (MHT) test and Carba-NP test. Multiplex PCR was done to identify the carbapenemase genes. Molecular typing of carbapenem-resistant isolates was performed by ERIC–PCR. RESULTS: We enrolled 1,210 patients admitted for 17,785 ICU days. Central catheters were utilized in 53.3% of patients for a total of 11,014 central line days. Out of 130 Gram-negative CLABSI pathogens detected, we identified carbapenem resistance in 57 (43.8%); of which K. pneumoniae was the predominant pathogen (27 out of 57, 47.4%). By MHT and carba-NP, 63.79% of K. pneumoniae isolates were carbapenemase producers. Multiplex PCR revealed bla(NDM) in 48.14% and bla(KPC) in 33.33% of the K. pneumoniae isolates, whereas bla(OXA-48) was not detected. ERIC-PCR analysis of 27 CRKP isolates showed genetic relatedness among only 5 KPC-positive and 2 producers, while most isolates were polyclonal. CONCLUSION: We detected a high rate of carbapenem resistance among K. pneumoniae causing CLABSI showing bla(NDM) in 48.14% and bla(KPC) in 33.33%; and they were mostly polyclonal. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254051/ http://dx.doi.org/10.1093/ofid/ofy210.1953 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kholy, Amany El
Manakhly, Arwa El
2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt
title 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt
title_full 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt
title_fullStr 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt
title_full_unstemmed 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt
title_short 2300. Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Causing Central Line Associated Blood Stream Infections (CLABSI) in Three ICU Units in Egypt
title_sort 2300. molecular epidemiology of carbapenem-resistant klebsiella pneumoniae (crkp) causing central line associated blood stream infections (clabsi) in three icu units in egypt
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254051/
http://dx.doi.org/10.1093/ofid/ofy210.1953
work_keys_str_mv AT kholyamanyel 2300molecularepidemiologyofcarbapenemresistantklebsiellapneumoniaecrkpcausingcentrallineassociatedbloodstreaminfectionsclabsiinthreeicuunitsinegypt
AT manakhlyarwael 2300molecularepidemiologyofcarbapenemresistantklebsiellapneumoniaecrkpcausingcentrallineassociatedbloodstreaminfectionsclabsiinthreeicuunitsinegypt